Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mr. Pink's Picks: selected event-driven value investments -- Ignore unavailable to you. Want to Upgrade?

To: Kip518 who wrote (9386)	6/11/1999 10:24:00 AM
From: Peter V	Respond to of 18998

I thought the MF article was positive, but then you get to the end: Frankly, I've learned to be skeptical of any supposedly revolutionary dental product. Investors who bought into the big plans of Enamelon (Nasdaq: ENML), Milestone Scientific (AMEX: MS), or Premier Laser Systems (Nasdaq: PLSIA) have suffered terribly. Pilaro had success in other ventures, and he's now brought in a new management team at BriteSmile. Even so, the history of the laser eye surgery market teaches caution about pricey cosmetic procedures that consumers must pay for themselves. Investors should ignore the hype and face the basic facts about BriteSmile. Here's a company with virtually no revenue today. It has managed to raise financing only by offering stock to investors at a discount to the market price. It's totally dependent on a new service that will require heavy marketing to inspire its targeted customers. The company also needs to open its own centers or negotiate deals with dentists or orthodontists, both time-consuming and costly prerequisites for generating revenues. And management has failed to meet some of its publicly stated goals. Putting a price on a good story is tricky, but BriteSmile's investors need to weigh the risks as well as the potential rewards.